Parnax Lab

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE383L01019
  • NSEID:
  • BSEID: 506128
INR
135.00
-0.6 (-0.44%)
BSENSE

Jun 18

BSE+NSE Vol: 6.21 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 286243,
    "name": "Parnax Lab",
    "stock_name": "Parnax Lab",
    "full_name": "Parnax Lab Ltd",
    "name_url": "stocks-analysis/parnax-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "135.00",
    "chg": -0.6,
    "chgp": "-0.44%",
    "dir": -1,
    "prev_price": "135.60",
    "mcapval": "154.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506128,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE383L01019",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "6.21 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/parnax-lab-286243-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 248,
    "sid": "286243",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/parnax-lab-286243"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Please find enclosed herewith the Annual Secretarial Compliance Report under reg. 24(A) for the Year ended March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Standalone & Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2026 Along With AuditorS Report Thereon.",
      "datetime": "28-May-2026",
      "details": "Board Meeting Outcome for Consideration and Approval of Standalone & Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2026 along with Auditors Report thereon and Re-appointment of Mr. Yogesh Varia as an Independent Director.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "28-May-2026",
      "details": "Please find enclosed herewith the Intimation regarding the Re-appointment of Mr. Yogesh K. Varia as an Independent Director of the Company for a second term of 5 consecutive years w.e.f. 28th May 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Please find enclosed herewith the Annual Secretarial Compliance Report under reg. 24(A) for the Year ended March 2026.

Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Standalone & Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2026 Along With AuditorS Report Thereon.

28-May-2026 | Source : BSE

Board Meeting Outcome for Consideration and Approval of Standalone & Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2026 along with Auditors Report thereon and Re-appointment of Mr. Yogesh Varia as an Independent Director.

Announcement under Regulation 30 (LODR)-Change in Management

28-May-2026 | Source : BSE

Please find enclosed herewith the Intimation regarding the Re-appointment of Mr. Yogesh K. Varia as an Independent Director of the Company for a second term of 5 consecutive years w.e.f. 28th May 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available